- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Baxter International Inc
+ Add to WatchlistBAX:US
71.5100 USD 0.6400 0.89%As of 20:04:02 ET on 05/24/2013.
Snapshot for Baxter International Inc (BAX)
| Open: | 72.0700 | Day's Range: | 71.3300 - 72.1000 | Volume: | 2,329,170 |
|---|---|---|---|---|---|
| Previous Close: | 71.5100 | 52wk Range: | 48.9800 - 73.9500 | 1-Yr Rtn: | +41.41% |
Key Statistics for BAX
| Current P/E Ratio (ttm) | 15.6425 |
|---|---|
| Estimated P/E(12/2013) | 15.3455 |
| Relative P/E vs. SPX | 0.9710 |
| Earnings Per Share (USD) (ttm) | 4.5715 |
| Est. EPS (USD) (12/2013) | 4.6600 |
| Est. PEG Ratio | 1.5922 |
| Market Cap (M USD) | 38,754.99 |
| Shares Outstanding (M) | 541.95 |
| 30 Day Average Volume | 4,286,244 |
| Price/Book (mrq) | 5.5736 |
| Price/Sale (ttm) | 2.7488 |
| Dividend Indicated Gross Yield | 2.74% |
| Cash Dividend (USD) | 0.4900 |
| Last Dividend | 06/05/2013 |
| 5 Year Dividend Growth | 16.96% |
| Next Earnings Announcement | 07/19/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BAX
Company Profile & Key Executives for BAX
Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company's products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
| Robert L Parkinson JrChairman/CEO | Robert J Hombach "Bob"VP/CFO |
| Robert M Davis "Rob"VP/Pres:Medical Products | Ludwig N HantsonVP/Pres:Bioscience |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BAX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page